CDKN2A and glioblastoma: These alterations concerned imbalances already described in GBM, such as gain of chromosome 7 with EGFR amplification, deletion of chromosome 10 with PTEN loss, and loss of CDKN2A/2B locus on chromosome 9 (Aubry et al., 2016).